ATE94386T1 - Gamma-linolensaeure oder dihomo-gamma-linolensaeure enthaltende zubereitung zur verbesserung der haut. - Google Patents

Gamma-linolensaeure oder dihomo-gamma-linolensaeure enthaltende zubereitung zur verbesserung der haut.

Info

Publication number
ATE94386T1
ATE94386T1 AT89302265T AT89302265T ATE94386T1 AT E94386 T1 ATE94386 T1 AT E94386T1 AT 89302265 T AT89302265 T AT 89302265T AT 89302265 T AT89302265 T AT 89302265T AT E94386 T1 ATE94386 T1 AT E94386T1
Authority
AT
Austria
Prior art keywords
linolenic acid
gamma linolenic
preparation containing
skin improvement
dihomo
Prior art date
Application number
AT89302265T
Other languages
English (en)
Inventor
David F Horrobin
John C M Stewart
Original Assignee
Scotia Holdings Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10633834&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE94386(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Scotia Holdings Plc filed Critical Scotia Holdings Plc
Application granted granted Critical
Publication of ATE94386T1 publication Critical patent/ATE94386T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/92—Oral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Apparatuses For Bulk Treatment Of Fruits And Vegetables And Apparatuses For Preparing Feeds (AREA)
AT89302265T 1988-03-22 1989-03-07 Gamma-linolensaeure oder dihomo-gamma-linolensaeure enthaltende zubereitung zur verbesserung der haut. ATE94386T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888806737A GB8806737D0 (en) 1988-03-22 1988-03-22 Therapeutic composition & method
EP89302265A EP0334507B1 (de) 1988-03-22 1989-03-07 Gamma-Linolensäure oder Dihomo-gamma-Linolensäure enthaltende Zubereitung zur Verbesserung der Haut

Publications (1)

Publication Number Publication Date
ATE94386T1 true ATE94386T1 (de) 1993-10-15

Family

ID=10633834

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89302265T ATE94386T1 (de) 1988-03-22 1989-03-07 Gamma-linolensaeure oder dihomo-gamma-linolensaeure enthaltende zubereitung zur verbesserung der haut.

Country Status (13)

Country Link
US (1) US4997657B1 (de)
EP (1) EP0334507B1 (de)
JP (1) JPH02149508A (de)
KR (1) KR890014088A (de)
AT (1) ATE94386T1 (de)
AU (1) AU609952B2 (de)
CA (1) CA1334003C (de)
DE (1) DE68909077T2 (de)
GB (1) GB8806737D0 (de)
HK (1) HK14294A (de)
IE (1) IE63646B1 (de)
NZ (1) NZ228330A (de)
ZA (1) ZA892002B (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0253706A (ja) * 1988-08-18 1990-02-22 Kurooda Japan Kk 化粧料組成物
GB8920228D0 (en) * 1989-09-07 1989-10-18 Efamol Holdings Fatty acid therapy
CA2119000A1 (en) * 1993-03-19 1994-09-20 David Frederick Horrobin Formulation for use in smokers
US5876438A (en) * 1993-08-02 1999-03-02 Houston Biotechnology Incorporated Polymeric device for the delivery of immunotoxins for the prevention of secondary cataract
AU711482B2 (en) * 1994-06-28 1999-10-14 Scotia Holdings Plc Compositions for treatment of diabetic complications
NO304009B1 (no) * 1997-02-04 1998-10-12 Gunnar Volden Hudpreparat
FR2765482B1 (fr) * 1997-07-07 2000-12-08 Oreal Utilisation de l'acide y-linolenique pour prevenir le stress oxydatif
JPWO2002083121A1 (ja) * 2001-04-12 2005-01-27 勝守 福本 皮膚環境の改善組成物とその衣服
US6688311B2 (en) * 2002-03-14 2004-02-10 Allergan, Inc. Method for determining effect of a clostridial toxin upon a muscle
US7140371B2 (en) * 2002-03-14 2006-11-28 Allergan, Inc. Surface topography method for determining effects of a botulinum toxin upon a muscle and for comparing botulinum toxins
DE10240989A1 (de) * 2002-09-05 2004-03-11 Uwe Klewinghaus Zusammensetzung und deren Verwendung als pharmazeutische oder kosmetische Formulierung zur äußerlichen Anwendung
US20050123500A1 (en) * 2003-01-31 2005-06-09 The Procter & Gamble Company Means for improving the appearance of mammalian hair and nails
EP1587377A2 (de) * 2003-01-31 2005-10-26 The Procter & Gamble Company Mittel zur verbesserung deserscheinungsbilds von säugetier-keratingewebe
WO2004103388A2 (en) * 2003-05-22 2004-12-02 Bioniche Life Sciences Inc. Insect repellent
CA2436650A1 (en) * 2003-08-06 2005-02-06 Naturia Inc. Conjugated linolenic acid (clnatm) compositions: synthesis, purification and uses
JP2006306812A (ja) * 2005-04-28 2006-11-09 Suntory Ltd 好酸球浸潤抑制剤
JP2006306813A (ja) * 2005-04-28 2006-11-09 Suntory Ltd 肥満細胞増殖抑制剤
EP3581178B1 (de) 2005-02-14 2023-08-30 Suntory Holdings Limited Zusammensetzung mit dihomo-(gamma)-linolensäure (dgla) als wirkstoff
JP5546087B2 (ja) * 2005-02-14 2014-07-09 サントリーホールディングス株式会社 皮膚疾患経口治療または予防剤
DE102007046202A1 (de) * 2007-09-26 2009-04-09 Schmidt-Philipp, Ingo Anwendung von Antioxidantien und ausgewählten Fettsäuren zur Linderung oder Verhütung von Schmerzen und anderer unerwünschter Körperreaktionen
GB0907413D0 (en) 2009-04-29 2009-06-10 Equateq Ltd Novel methods
US8293790B2 (en) 2011-10-19 2012-10-23 Dignity Sciences Limited Pharmaceutical compositions comprising DGLA and benzoyl peroxide and methods of use thereof
JP2012082226A (ja) * 2012-01-25 2012-04-26 Suntory Holdings Ltd 皮膚疾患経口治療または予防剤
MX375328B (es) 2014-06-04 2025-03-06 Ds Biopharma Ltd Composiciones farmacéuticas que comprenden ácido dihomo-gamma-linolénico (dgla) y uso de las mismas
JP6214474B2 (ja) * 2014-06-10 2017-10-18 サントリーホールディングス株式会社 皮膚疾患経口治療または予防剤
JP6203320B2 (ja) * 2016-04-12 2017-09-27 サントリーホールディングス株式会社 皮膚疾患経口治療または予防剤
JP6462790B2 (ja) * 2017-07-20 2019-01-30 サントリーホールディングス株式会社 皮膚疾患経口治療または予防剤
US20210315851A1 (en) 2020-04-03 2021-10-14 Afimmune Limited Compositions comprising 15-hepe and methods of treating or preventing hematologic disorders, and/or related diseases
WO2024106446A1 (ja) * 2022-11-15 2024-05-23 株式会社ニッスイ アレルギー性鼻炎またはアレルギー性結膜炎の症状の軽減または予防用組成物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4273763A (en) * 1978-01-23 1981-06-16 Efamol Limited Pharmaceutical and dietary compositions
AU556817B2 (en) * 1982-02-03 1986-11-20 Efamol Limited Topical application of a lithium salt and dihomo-alpha- linolenic acid
GB8302708D0 (en) * 1983-02-01 1983-03-02 Efamol Ltd Pharmaceutical and dietary composition
US4568343A (en) * 1984-10-09 1986-02-04 Alza Corporation Skin permeation enhancer compositions

Also Published As

Publication number Publication date
DE68909077T2 (de) 1994-03-03
NZ228330A (en) 1993-10-26
KR890014088A (ko) 1989-10-21
IE63646B1 (en) 1995-05-31
EP0334507A3 (de) 1991-04-17
EP0334507A2 (de) 1989-09-27
GB8806737D0 (en) 1988-04-20
JPH02149508A (ja) 1990-06-08
HK14294A (en) 1994-03-04
DE68909077D1 (de) 1993-10-21
US4997657B1 (en) 1995-05-02
EP0334507B1 (de) 1993-09-15
AU3122789A (en) 1989-09-28
AU609952B2 (en) 1991-05-09
ZA892002B (en) 1989-11-29
IE890769L (en) 1989-09-22
US4997657A (en) 1991-03-05
CA1334003C (en) 1995-01-17

Similar Documents

Publication Publication Date Title
US4997657B1 (en) Method for improving skin smoothness.
NO2002009I2 (no) Tiotropium
GR3003991T3 (de)
JPS6430579A (en) Support bacteria composition and its production
RO102513B1 (en) Composition for improving plants growing
EP0276543A3 (de) Verwendung von Buspiron zur Verbesserung des Kurzzeitgedächtnisses
HUT44438A (en) Composition comprising l-dopa
EP0265099A3 (en) Nutrient composition
EP0152273A3 (en) A phenylpiperidine derivative, and its salts, their preparation, compositions containing them, and their therapeutic use
AU1840788A (en) Compositions having hair growth stimulating activity
FI882627A0 (fi) Vaevnads plasminogenaktivatoranaloger med modifierade vaextfaktorregioner.
ZA879011B (en) Variants of hirudin,their use and their preparation
PH24796A (en) A method of preventing aids by using a didioxynucleoside analog
IL85189A (en) Beta-alkyl substituted melatonins,their preparation and pharmaceutical compositions containing them
DE3764235D1 (de) Ifosfamid-lyophilisat und verfahren zu dessen herstellung.
HUT47600A (en) Process for production of encephalinase glykopeptids, amin acid derivatives with hindering effect and medical compositions containing them
EP0177965A3 (en) Novel oxa- and thiadiazolyl derivatives and their use
ZA857721B (en) Process for treatment of rheumatic diseases
GB2206903B (en) Concentrated compositions and their use as stabilizers for peroxide-containing alkaline liquors
GB8714394D0 (en) Clubs rackets &c
NZ225019A (en) Thiophene derivatives and processes for preparing them, and their use in the preparation of n-(2,4-dimethylthien-3-yl)-n-(1-methoxyprop-2-yl)-chloroacetamide
GB8901463D0 (en) Process for the preparation and use of antidote-carrying micro-and macroorganisms,useful for lowering the cultivated plant-damaging effect of thiolcarbamates
IL70620A0 (en) Azolylpropane derivatives,their preparation and their use as plant growth regulants
PL277260A1 (en) Method of obtaining novel derivatives of tetrahydropyridine
JPS6426557A (en) Novel 1-benzenesulfonyl-2-oxo-5-alkylthiopyrrolidine derivatives, manufacture, intermediates, use as drug and composition